A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cell (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Feb 2019
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Wounds
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
- 20 Feb 2019 Last check against ClinicalTrials.gov: US National Institutes of Health
- 10 Feb 2019 Planned End Date changed from 1 Jun 2019 to 1 Dec 2020.
- 10 Feb 2019 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2019.